Social & QoL Behaviors in Parkinson's Disease
Launched by GREGORY WALLACE · Apr 23, 2024
Trial Information
Current as of September 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how Parkinson's Disease affects people's social behaviors and overall quality of life compared to individuals without the disease who are of the same age. Researchers want to understand the unique challenges faced by adults living with Parkinson's, which can range from difficulties in daily activities to changes in how they interact with others.
To participate, you need to be at least 40 years old. If you have Parkinson's Disease diagnosed by a healthcare professional, you can join the Parkinson's group. If you don’t have Parkinson's but are also over 40, you may qualify for the neurotypical group. Unfortunately, individuals with developmental disabilities, like autism or Down syndrome, are not eligible for this study. Participants will share their experiences, allowing researchers to gather valuable information that can help improve the lives of people living with Parkinson's. If you or someone you know fits these criteria and is interested, this could be a great opportunity to contribute to important research!
Gender
ALL
Eligibility criteria
- • Parkinson's disease group
- Inclusion Criteria:
- • Have been diagnosed with Parkinsons Disease by a healthcare professional
- • Are at least 40 years old
- Exclusion Criteria:
- • Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
- • Neurotypical group
- Inclusion Criteria:
- • Are at least 40 years old
- Exclusion Criteria:
- • Have been diagnosed with Parkinson's disease by a healthcare professional
- • Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
About Gregory Wallace
Gregory Wallace is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on ethical practices and rigorous scientific methodology, the organization collaborates with leading healthcare professionals and institutions to design and implement clinical trials across various therapeutic areas. By fostering a culture of transparency and accountability, Gregory Wallace ensures the highest standards of safety and efficacy in the development of new treatments, ultimately contributing to the enhancement of healthcare solutions worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Patients applied
Trial Officials
Gregory Wallace, PhD
Principal Investigator
George Washington University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported